Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20111
20131
20144
20151
20162
20172
20181
20192
20203
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Recruiting2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Bellus Health Inc. - a GSK company2
Merck Sharp & Dohme LLC2
United Therapeutics2
Vertex Pharmaceuticals Incorporated2
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Hoffmann-La Roche1
Medicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases23
Lung Diseases15
Bronchial Diseases8
Lung Diseases, Obstructive7
Asthma6
Chronic Cough4
Cough4
Pathologic Processes4
Respiration Disorders4
Signs and Symptoms, Respiratory4

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.